Investigation of cytochrome p450 isoforms 1A1, 1B1 and 2W1 as targets for therapeutic intervention in head and neck cancer. Probing CYP1A1, 1B1 and 2W1 activity with duocarmycin bioprecursors

Description

The full text will be available at the end of the embargo: 30th July 2026

Links & Downloads

1. http://hdl.handle.net/10454/18171

Tags

Cytochrome P450 (CYP)

CYP1A1

CYP1B1

CYP2W1

Head and Neck Cancer (HNC)

Duocarmycin

Prodrug

Bioprecursor

DNA damage

Therapeutic intervention

Additional Fields

Identifer	oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/18171
Date	January 2018
Creators	Presa, Daniela
Contributors	Patterson, Laurence H., McCaul, Jim, Pors, Klaus
Publisher	University of Bradford, Institute of Cancer Therapeutics, Faculty of Life Sciences
Source Sets	Bradford Scholars
Language	English
Detected Language	English
Type	Thesis, doctoral, PhD
Rights	<a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.